Description

Anthrax Vaccine Market:

Anthrax is a severe infectious disease caused by bacillus anthracis. Signs and symptoms include vomiting, nausea, abdominal pain, headache, and loss of appetite, fever, severe bloody diarrhoea in the later stages of the disease, sore throat, and difficulty swallowing. Risk factors for anthrax include injection of illegal drugs, handling animal skins, and working in veterinary medicine, especially dealing with livestock. Global anthrax vaccine market is driven by growing threat of communicable diseases such as anthrax across the globe. Moreover cost-effectiveness of immunizations, new funding opportunities from government, donors, research foundations, advances in research and manufacturing technologies expected to drive market revenue growth of anthrax vaccine over a forecast period. In addition, availability of large target population in emerging markets driving the growth of the anthrax vaccines market. However, lack of awareness, the high cost of the vaccine in under developed economies, lack of availability and affordability, stringent regulations are the factors which are restraining the growth of the market.

 

Anthrax Vaccine Market

Anthrax Vaccine Market

Anthrax Vaccine Market Outlook

 

Global anthrax vaccine market is segmented based on the type of vaccine, end user and geographical regions.

 

On the basis of type of vaccine,this market is segmented as

  • Live Vaccines
  • Cell free PA Vaccines

 

 On basis of end user, this is segmented as

  • Hospitals
  • Clinics
  • Vaccination Centers
  • Others

 

The growing efforts and of interest market players in expanding the product portfolio related to anthrax prevention are expected to to impel the market growth over the forecast period. Growing government funding in the United States to generate and store sufficient vaccines against anthrax through various programs, such as Joint Program Executive Office for Chemical and Biological Defense, Biomedical Advanced Research and Development Authority (BARDA), BioShield Legislation and is creating market opportunities for the market players. One of the U.S. FDA approved products against anthrax is BioThrax, manufactured by Emergent BioDefense Operations Lansing LLC, for active immunization against anthrax.

 

Geographically, global anthrax vaccine market is segmented into five key regions Viz. North America, Europe, Asia-Pacific, Latin America, and The Middle East & Africa. North America market expected to present better growth opportunities for market players owing to government initiatives to curb anthrax. The presence of various ongoing programs under the organizations such as BARDA, HHSCDC, NIAID, ASPR, and the FDA is one of the key contributing factors for the revenue generation in North America region. Asia Pacific is expected to witness a significant demand on account of surging investments in the R&D sector. The extensive vaccine manufacturing facilities across Japan coupled with the presence of sophisticated healthcare infrastructure in the country is contributing to its strong market position.

 

Some of the players in the anthrax vaccines market are Emergent BioSolutions (US), Elusys Therapeutics (US), Porton Biopharma Limited (UK), and Panacea Biotec (India) to name a few.

 

  • In 2015, Emergent BioDefense Operations Lansing LLC received U.S. FDA approval for its BioThrax, a vaccine for Anthrax.

 

Report Outline:

  • The report provides granular level information about the market size, regional market share and forecast from 2017-2023
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario


Location

GEOGRAPHY

PBI Location Map

1. Executive summary
 
2. Global Anthrax Market Introduction
2.1. Global Anthrax Market – Taxonomy
2.2. Global Anthrax Market –Definitions
2.2.1. Type of vaccine
2.2.2. End User

3. Global Anthrax Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Anthrax Market Dynamics – Factors Impact Analysis
3.6. Global Anthrax Market – Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
3.6.4. China
3.7. Global Anthrax Market – Product Innovations

4. Global Anthrax Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. Global Anthrax Market, By Type of Vaccine, 2013 – 2017 and Forecast, 2018 – 2024
5.1. Live Vaccine
5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.1.3. Market Opportunity Analysis
5.2. Cell Free PA Vaccine
5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.2.3. Market Opportunity Analysis

6. Global Anthrax Market Forecast, By End user, 2013 – 2017 and Forecast, 2018 – 2024
6.1. Hospitals
6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.1.3. Market Opportunity Analysis
6.2. Clinics
6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.3. Vaccination Centres
6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.4.3. Market Opportunity Analysis

7. Global Anthrax Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024
7.1. North America
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.5.3. Market Opportunity Analysis
7.6. Global Anthrax Market – Opportunity Analysis Index, By Type of Vaccine, End User, and Region, 2018 – 2024

8. North America Anthrax Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
8.1.1. Type of Vaccine Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1.1. Live Vaccines
8.1.1.2. Cell free PA Vaccines
8.1.2. End User Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.1.2.1. Hospitals
8.1.2.2. Clinics
8.1.2.3. Vaccination Centres
8.1.2.4. Others
8.1.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.1.3.1. U.S.
8.1.3.2. Canada
8.1.4. North America Anthrax Market – Opportunity Analysis Index, By Type of vaccine, End User and Country, 2018 – 2024
8.1.5. North America Anthrax Market Dynamics – Trends

9. Europe Anthrax Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
9.1.1. Type of Vaccine Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1.1. Live Vaccines
9.1.1.2. Cell free PA Vaccines
9.1.2. End User Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.2.1. Hospitals
9.1.2.2. Clinics
9.1.2.3. Vaccination Centres
9.1.2.4. Others
9.1.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.3.1. Germany
9.1.3.2. UK
9.1.3.3. France
9.1.3.4. Spain
9.1.3.5. Italy
9.1.3.6. Russia
9.1.3.7. Poland
9.1.3.8. Rest of Europe
9.1.4. Europe Anthrax Market – Opportunity Analysis Index, By Type of Vaccine, End user and Country, 2018 – 2024
9.1.5. Europe Anthrax Market Dynamics – Trends

10. Asia-Pacific Anthrax Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
10.1.1. Type of Vaccine Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Live Vaccines
10.1.1.2. Cell free PA Vaccines
10.1.2. End User Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Hospitals
10.1.2.2. Clinics
10.1.2.3. Vaccination Centres
10.1.2.4. Others
10.1.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
10.1.3.1. Japan
10.1.3.2. China
10.1.3.3. India
10.1.3.4. ASEAN
10.1.3.5. Australia & New Zealand
10.1.3.6. Rest of Asia-Pacific
10.1.4. Asia-Pacific Anthrax Market – Opportunity Analysis Index, By Type of vaccine, End-User and Country, 2018 – 2024
10.1.5. Europe Anthrax Market Dynamics – Trends

11. Latin America Anthrax Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
11.1.1. Type of Vaccine Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Live Vaccines
11.1.1.2. Cell free PA Vaccines
11.1.2. End User Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Hospitals
11.1.2.2. Clinics
11.1.2.3. Vaccination Centres
11.1.2.4. Others
11.1.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Brazil
11.1.3.2. Mexico
11.1.3.3. Argentina
11.1.3.4. Venezuela
11.1.3.5. Rest of Latin America
11.1.4. Latin America Anthrax Market – Opportunity Analysis Index, By Type of Vaccine, End User and Country, 2018 – 2024
11.1.5. Latin America Anthrax Market Dynamics – Trends

12. Middle East and Africa Anthrax Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
12.1.1. Type of Vaccine Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Live Vaccines
12.1.1.2. Cell free PA Vaccines
12.1.2. End User Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Hospitals
12.1.2.2. Clinics
12.1.2.3. Vaccination Centres
12.1.2.4. Others
12.1.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.3.1. Gulf Cooperation Council (GCC) Countries
12.1.3.2. Israel
12.1.3.3. South Africa
12.1.3.4. Rest of MEA
12.1.4. MEA Anthrax Market – Opportunity Analysis Index, By Type of Vaccine, End-User and Country, 2018 – 2024
12.1.5. MEA Anthrax Market Dynamics – Trends

13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Emergent BioSolutions (U.S)
13.2.2. Elusys Therapeutics (U.S.)
13.2.3. Porton Biopharma Limited (UK)
13.2.4. Panacea Biotec (India)

14. Research Methodology
 
15. Key Assumptions and Acronyms

Ask An Analyst
Request Customisation

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX